First Time Loading...
P

Pear Therapeutics Inc
NASDAQ:PEAR

Watchlist Manager
Pear Therapeutics Inc
NASDAQ:PEAR
Watchlist
Price: 0.0077 USD -15.38% Market Closed
Updated: May 7, 2024

Pear Therapeutics Inc
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Pear Therapeutics Inc
Cash from Financing Activities Peer Comparison

Comparables:
VEEV
INSP
EVH
DOCS
GDRX

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
P
Pear Therapeutics Inc
NASDAQ:PEAR
Cash from Financing Activities
$2.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Veeva Systems Inc
NYSE:VEEV
Cash from Financing Activities
-$16.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Inspire Medical Systems Inc
NYSE:INSP
Cash from Financing Activities
$14m
CAGR 3-Years
-53%
CAGR 5-Years
-41%
CAGR 10-Years
N/A
Evolent Health Inc
NYSE:EVH
Cash from Financing Activities
$281.3m
CAGR 3-Years
N/A
CAGR 5-Years
1%
CAGR 10-Years
N/A
Doximity Inc
NYSE:DOCS
Cash from Financing Activities
-$74.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Goodrx Holdings Inc
NASDAQ:GDRX
Cash from Financing Activities
-$167.4m
CAGR 3-Years
N/A
CAGR 5-Years
-47%
CAGR 10-Years
N/A

See Also

What is Pear Therapeutics Inc's Cash from Financing Activities?
Cash from Financing Activities
2.2m USD

Based on the financial report for Dec 31, 2022, Pear Therapeutics Inc's Cash from Financing Activities amounts to 2.2m USD.

What is Pear Therapeutics Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 1Y
-99%

Over the last year, the Cash from Financing Activities growth was -99%.